Form 4: OptimizeRx CBO Disposes Shares for Tax Obligations

OptimizeRx Chief Business Officer Andrew J. D'Silva disposed of shares to cover tax withholding obligations on October 1 and October 3, 2025.

Summary

• Andrew J. D'Silva, Chief Business Officer of OptimizeRx Corp (OPRX), reported dispositions of common stock.
• The transactions occurred on October 1, 2025, and October 3, 2025.
• On October 1, 2025, 414 shares were disposed of at a price of $18.98 per share.
• On October 3, 2025, 794 shares were disposed of at a price of $18.75 per share.
• These shares were withheld by the Issuer to satisfy D'Silva's tax withholding obligations, which is treated as a disposition under Section 16.
• Following these transactions, D'Silva beneficially owns 46,306 shares of common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine, non-discretionary disposition of shares for tax withholding purposes, which is a neutral event and does not reflect positively or negatively on the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction related to tax withholding obligations, which is a common occurrence for executives receiving equity compensation across all industries. It does not reflect specific industry trends or company-specific operational performance.

Comparison to Industry Standards

• Tax withholding on equity compensation is a standard practice for publicly traded companies across all sectors, including healthcare technology, where OptimizeRx operates.
• The reported disposition of shares to cover tax liabilities is a non-discretionary event, consistent with typical compensation structures for executives in comparable companies.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or strategic direction.
• Employees: No direct impact on the broader employee base.

Key Dates

Recommendation

This Form 4 reports a non-discretionary disposition of shares by the Chief Business Officer to cover tax withholding obligations, a routine event for equity compensation. It does not indicate any change in the officer's conviction in the company's prospects or a discretionary sale. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

OptimizeRx, OPRX, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Andrew J. D'Silva